In December 2025, Castle Biosciences reported Nature Communications data from the largest prospective, multicenter uveal melanoma study showing that combining its DecisionDx-UM test with PRAME gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback